Jonas Hallén
Chief Medical Officer Calluna Pharma
Seminars
Thursday 21st August 2025
Restoring Lung Homeostasis: A Dual-Target Approach to Treating IPF through Epithelial Repair and Inflammation Modulation
4:10 pm
- Addressing IPF at the Source: Targeting the dysfunctional crosstalk between the epithelium and immune system as a root cause of disease progression.
- EPHX2 Inhibition as a First-in-Class Strategy: Leveraging sEH inhibition to resolve inflammation and restore lipid signaling pathways essential for epithelial barrier integrity.
- A New Era in Anti-Fibrotic Therapy: Integrating insights from lung homeostasis biology to inform preclinical validation and future clinical translation
